TY - JOUR
T1 - Pathobionts in the Vaginal Microbiota
T2 - Individual Participant Data Meta-Analysis of Three Sequencing Studies
AU - van de Wijgert, Janneke H H M
AU - Verwijs, Marijn C
AU - Gill, A Christina
AU - Borgdorff, Hanneke
AU - van der Veer, Charlotte
AU - Mayaud, Philippe
N1 - Funding Information:
The Rwanda VMB study was supported by the DFID/MRC/Wellcome Trust Joint Global Health Trials Scheme as a Development Project [grant reference MR/M017443/1; grant title: Preparing for a clinical trial of interventions to maintain normal vaginal microbiota for preventing adverse reproductive health outcomes in Africa] and the University of Liverpool [institutional funding for the 16S rRNA sequencing]. The HARP study was funded by the European Commission 7th Framework Programme [original HARP study; grant agreement number HEALTH-2010-F2-265396] and the University of Liverpool [institutional funding for the 16S rRNA sequencing]. The HELIUS study is conducted by the Academic Medical Center Amsterdam and the Public Health Service of Amsterdam. Both organizations provided core support for HELIUS [institutional funding]. The HELIUS study is also funded by the Dutch Heart Foundation [grant number 2010T084], the Netherlands Organization for Health Research and Development (ZonMw) [grant number 200500003], the European Union (FP-7) [grant number 278901], and the European Fund for the Integration of non-EU immigrants (EIF) [grant number 278901]. The HELIUS VMB Study reported here was additionally supported by the Aids Fonds Netherlands [grant number 201102] and the Netherlands Organization for Health Research and Development (ZonMw) [grant numbers 7115 0001 and 204005002]. Some HELIUS analyses were carried out on the Dutch national e-infrastructure with the support of SURF Foundation. The views expressed in this paper are those of the authors and do not necessarily represent the views of the authors' institutions or the funders.
Publisher Copyright:
© Copyright © 2020 van de Wijgert, Verwijs, Gill, Borgdorff, van der Veer and Mayaud.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/4/15
Y1 - 2020/4/15
N2 - Sequencing studies have shown that optimal vaginal microbiota (VMB) are lactobacilli-dominated and that anaerobes associated with bacterial vaginosis (BV-anaerobes) are commonly present. However, they overlooked a less prevalent but more pathogenic group of vaginal bacteria: the pathobionts that cause maternal and neonatal infections and pelvic inflammatory disease. We conducted an individual participant data meta-analysis of three VMB sequencing studies that included diverse groups of women in Rwanda, South Africa, and the Netherlands (2,044 samples from 1,163 women in total). We identified 40 pathobiont taxa but only six were non-minority taxa (at least 1% relative abundance in at least one sample) in all studies: Streptococcus (54% of pathobionts reads), Staphylococcus, Enterococcus, Escherichia/Shigella, Haemophilus, and Campylobacter. When all pathobionts were combined into one bacterial group, the VMB of 17% of women contained a relative abundance of at least 1%. We found a significant negative correlation between relative abundances (ρ = -0.9234), but not estimated concentrations (r = 0.0031), of lactobacilli and BV-anaerobes; and a significant positive correlation between estimated concentrations of pathobionts and BV-anaerobes (r = 0.1938) but not between pathobionts and lactobacilli (r = 0.0436; although lactobacilli declined non-significantly with increasing pathobionts proportions). VMB sequencing data were also classified into mutually exclusive VMB types. The overall mean bacterial load of the ≥20% pathobionts VMB type (5.85 log10 cells/μl) was similar to those of the three lactobacilli-dominated VMB types (means 5.13-5.83 log10 cells/μl) but lower than those of the four anaerobic dysbiosis VMB types (means 6.11-6.87 log10 cells/μl). These results suggest that pathobionts co-occur with both lactobacilli and BV-anaerobes and do not expand as much as BV-anaerobes do in a dysbiotic situation. Pathobionts detection/levels were increased in samples with a Nugent score of 4-6 in both studies that conducted Nugent-scoring. Having pathobionts was positively associated with young age, non-Dutch origin, hormonal contraceptive use, smoking, antibiotic use in the 14 days prior to sampling, HIV status, and the presence of sexually transmitted pathogens, in at least one but not all studies; inconsistently associated with sexual risk-taking and unusual vaginal discharge reporting; and not associated with vaginal yeasts detection by microscopy. We recommend that future VMB studies quantify common vaginal pathobiont genera.
AB - Sequencing studies have shown that optimal vaginal microbiota (VMB) are lactobacilli-dominated and that anaerobes associated with bacterial vaginosis (BV-anaerobes) are commonly present. However, they overlooked a less prevalent but more pathogenic group of vaginal bacteria: the pathobionts that cause maternal and neonatal infections and pelvic inflammatory disease. We conducted an individual participant data meta-analysis of three VMB sequencing studies that included diverse groups of women in Rwanda, South Africa, and the Netherlands (2,044 samples from 1,163 women in total). We identified 40 pathobiont taxa but only six were non-minority taxa (at least 1% relative abundance in at least one sample) in all studies: Streptococcus (54% of pathobionts reads), Staphylococcus, Enterococcus, Escherichia/Shigella, Haemophilus, and Campylobacter. When all pathobionts were combined into one bacterial group, the VMB of 17% of women contained a relative abundance of at least 1%. We found a significant negative correlation between relative abundances (ρ = -0.9234), but not estimated concentrations (r = 0.0031), of lactobacilli and BV-anaerobes; and a significant positive correlation between estimated concentrations of pathobionts and BV-anaerobes (r = 0.1938) but not between pathobionts and lactobacilli (r = 0.0436; although lactobacilli declined non-significantly with increasing pathobionts proportions). VMB sequencing data were also classified into mutually exclusive VMB types. The overall mean bacterial load of the ≥20% pathobionts VMB type (5.85 log10 cells/μl) was similar to those of the three lactobacilli-dominated VMB types (means 5.13-5.83 log10 cells/μl) but lower than those of the four anaerobic dysbiosis VMB types (means 6.11-6.87 log10 cells/μl). These results suggest that pathobionts co-occur with both lactobacilli and BV-anaerobes and do not expand as much as BV-anaerobes do in a dysbiotic situation. Pathobionts detection/levels were increased in samples with a Nugent score of 4-6 in both studies that conducted Nugent-scoring. Having pathobionts was positively associated with young age, non-Dutch origin, hormonal contraceptive use, smoking, antibiotic use in the 14 days prior to sampling, HIV status, and the presence of sexually transmitted pathogens, in at least one but not all studies; inconsistently associated with sexual risk-taking and unusual vaginal discharge reporting; and not associated with vaginal yeasts detection by microscopy. We recommend that future VMB studies quantify common vaginal pathobiont genera.
KW - Enterococcus
KW - Escherichia
KW - Staphylococcus
KW - Streptococcus
KW - bacterial vaginosis
KW - ethnicity
KW - pathobionts
KW - vaginal microbiota
UR - http://www.scopus.com/inward/record.url?scp=85083967283&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2020.00129
DO - 10.3389/fcimb.2020.00129
M3 - Article
C2 - 32351902
SN - 2235-2988
VL - 10
SP - 1
EP - 20
JO - Frontiers in cellular and infection microbiology
JF - Frontiers in cellular and infection microbiology
M1 - 129
ER -